Although weight-loss specific drugs are now licensed, supply is limited, and as a consequence, off-label prescribing of diabetic drugs has continued to grow (particularly of Ozempic (active ingredient: semaglutide) and Mounjaro (active ingredient: tirzepatide))
Chou CC, Pan SY, Sheen YJ, Lin JF, Lin CH, Lin HJ, et al
Over time, these changes help support healthier eating patterns and make it easier to achieve and maintain a healthier weight under supervision
Third-Party Consumer Feedback Platforms : This article references third-party consumer feedback platforms in general category terms only
In practice, some pharmacies sell it without a prescription, but this is technically against COFEPRIS regulations